Aeterna Zentaris Reports Fourth Quarter and Full-Year 2017 Financial and Operating Results Biotech Investing
Cellectar Granted Seminal U.S. Patent for Phospholipid-Ether Analogs as Cancer-Targeting Drug Vehicles Pharmaceutical Investing
Arch Biopartners Announces Issuance of U.S. Patent for Its Novel Antibacterial Drug AB569 Biotech Investing
AnaptysBio Announces Positive Top-Line Proof-of-Concept Data For ANB020 In Moderate-to-Severe Baseline Biotech Investing
Seegnal Inc. Receives Gold Mark from the Standards Institution of Israel, Advancing Commercialization Readiness